ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Net income 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$59.5MFY2025 · since FY2017: -$42.8M → -$59.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.5M | +62.7% |
| FY2024 | -$159.5M | +29.2% |
| FY2023 | -$225.3M | -12.5% |
| FY2022 | -$200.2M | +3.4% |
| FY2021 | -$207.3M | -41.8% |
| FY2020 | -$146.2M | -113.1% |
| FY2019 | -$68.6M | -47.7% |
| FY2018 | -$46.4M | -8.4% |
| FY2017 | -$42.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice